Identification of a sixteen-microRNA signature as prognostic biomarker for stage II and III colon cancer

Despite advances in colon cancer research and novel therapies, high risk of recurrence remains a major challenge. This study reports miRNA expression profiling as a biomarker for the prognosis of TNM stage II and III colon cancer. Fresh frozen biopsies from the study cohort (N=111) were analyzed for...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacob, Havjin, Stanisavljevic, Luka, Storli, Kristian Eeg, Hestetun, Kjersti E, Dahl, Olav, Myklebust, Mette P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5675676/
https://www.ncbi.nlm.nih.gov/pubmed/29152124
http://dx.doi.org/10.18632/oncotarget.21237

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5675676/
https://www.ncbi.nlm.nih.gov/pubmed/29152124
http://dx.doi.org/10.18632/oncotarget.21237

Ejemplares similares